McKenney, A. ., Lau, A. ., Somasundara, A. ., Spitzer, B. ., Intlekofer, A. ., Ahn, J. ., … Levine, R. . (2018). JAK2/IDH-mutant-driven myeloproliferative neoplasm is sensitive to combined targeted inhibition. The Journal of Clinical Investigation. https://doi.org/10.1172/JCI94516 (Original work published 2018)